Qinli Sun
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections.
Journal: Science immunology
Published: July 31, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.
Journal: Science (New York, N.Y.)
Published: February 19, 2026
Selective Immune Silencing by Targeted TGF-β Agonists.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
Bispecific T cell engagers control solid tumors through clonal replacement and IL2-driven effector differentiation of CD8 T cells.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.
Journal: Science (New York, N.Y.)
Published: November 13, 2025
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.
Journal: Nature
Published: June 18, 2025
Selective expansion of TCF7-expressing tumor-reactive T cell subpopulations during ovarian tumor-infiltrating T cell production ex vivo.
Journal: Science China. Life sciences
Published: March 10, 2025
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.
Journal: The Journal of experimental medicine
Published: January 01, 2025
Analysis of the three-dimensional genome of exhausted CD8+ T cells reveals a critical role of IRF8 in their differentiation and functions in cancer.
Journal: Nature immunology
Published: October 28, 2024
Last Updated: 09/26/2026